Taro Pharmaceutical Industries Ltd (TARO) on Tuesday reported fourth-quarter net earnings of $152.3 million or $3.56 per share compared with $89.6 million or $2.10 per share last year.
Revenues for the quarter were higher at $244.2 million compared with $187.2 million in the prior year.
A measure of future economic activity in Germany rose for a fifth consecutive month in March on widespread strength among components, signalling that the growth momentum could improve in coming months, survey figures from the Conference Board revealed Wednesday.
The Conference Board Leading Economic...
Germany Mar CB Coincident Index Down 0.2%
Germany Mar CB Leading Index Up 0.5%